Ara M. Abramyan

Nov 8, 2023 | biorxiv.org | Noah Xue Hamlish |Ara M. Abramyan |Alanna Schepartz

AbstractSequence-defined biomaterials whose monomer backbones diverge from canonical alpha-amino acids represents the next frontier in protein and biomaterial evolution with the potential to yield better biological therapeutics, bioremediation tools, and biodegradable plastic-like materials. One monomer family of particular interest for biomaterials are beta-hydroxy acids.